Hospitals FDA Clears SpinalCyte IND Application for Universal Donor Cell Therapy to Treat Lower Back Pain byJosh SandbergNovember 28, 2018
Spine Top Stories SpinalCyte Announces Positive 12 Month Pain Data From Phase 1/Phase 2 Clinical Trial for Degenerative Disc Disease byChris StewartOctober 25, 2018
Biologics SpinalCyte Announces Publication Supporting the Therapeutic Effects of Fibroblast Cell Therapy in Disc Degeneration and Inflammation in The Spine Journal byJosh SandbergOctober 11, 2018
Biologics SpinalCyte to Feature Fibroblast-Based Cell Therapy Results at the 2018 North American Spine Society Annual Meeting byJosh SandbergSeptember 24, 2018
Biologics SpinalCyte Announces Publication of Fibroblast Cell Therapy Review in the Journal of Translational Medicine byJosh SandbergJuly 31, 2018
Hospitals SpinalCyte Applies with FDA to Expand Human Clinical Trial of CybroCell™ Dermal Fibroblasts as Investigational New Drug (IND) byJosh SandbergApril 12, 2018
